Synthetic Triterpenoid Binds to mTOR Molecular Targets
Author Information
Author(s): Yore Mark M., Kettenbach Arminja N., Sporn Michael B., Gerber Scott A., Liby Karen T.
Primary Institution: Dartmouth Medical School
Hypothesis
The study aims to characterize the target profile of the synthetic oleanane triterpenoid CDDO-Imidazolide (CDDO-Im) and its interaction with mTOR.
Conclusion
The study confirms that CDDO-Im directly targets mTOR and inhibits its kinase activity, affecting various signaling pathways.
Supporting Evidence
- The study identified 577 candidate binding proteins for CDDO-Im.
- CDDO-Im was shown to block insulin-induced activation of the mTOR pathway.
- The proteomic analysis revealed interconnected signaling networks targeted by CDDO-Im.
Takeaway
Researchers found that a new drug called CDDO-Im can stick to a protein called mTOR and stop it from working, which might help treat diseases.
Methodology
The study used affinity purification combined with mass spectrometry to identify protein binding partners of CDDO-Im in cell culture.
Potential Biases
The presence of highly abundant low-affinity proteins may complicate the identification of direct targets.
Limitations
The qualitative nature of the proteomics approach may not provide quantitative information about the SO-target interactions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website